Fundamental Research Corporation
  • Home
  • About Us
    • About Us
    • OUR TEAM
    • Careers
  • Content
    • Latest Research Reports
    • Analysts’ Ideas of the Week
    • All Covered Companies
  • TOP PICKS
  • Videos
    • Analysts’ Ideas
    • Introduction to Investing Series
    • The Expert Network Series
    • Webinars
    • Other Videos
  • Subscribe For Free
  • Log in

Select Page

Company Name: Lexaria Bioscience Corp.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Drug Delivery Tech With Multiple Mainstream Applications – Resuming Coverage

Lexaria Bioscience Corp. (NASDAQ: LEXX) Drug Delivery Tech With Multiple Mainstream Applications – Resuming Coverage

Aug 16, 2021

Highlights Lexaria’s DehydraTECHTM is a patented and proprietary drug delivery technology for...

Read More

Lexaria Bioscience (CSE: LXX) Focus Seemingly on R&D as Licensing Revenues Slow

May 7, 2019

Read More

Lexaria Bioscience (CSE: LXX) Landmark Partnership with Tobacco Titan

Feb 5, 2019

Read More

Lexaria (CSE: LXX) Additional Licensees and Expanded IP

Aug 31, 2018

Read More

Lexaria (OTCQX: LXRP / CSE: LXX) Initial Cannabis Focus; Multi-Market Potential

Jan 12, 2018

Read More

© 2003 - 2023 Fundamental Research Corp. All Rights Reserved.

Most companies on this website are covered by FRC under an issuer paid model; see the important disclosure at the back of every report.

  • Home
  • Coverage List
  • About Us
  • Careers
  • Subscription
  • Contact
  • FRC CAP